We are excited to invite you to an evening of short and sharp presentations that look at new research topics presented by our promising higher degree research students.
A buffet dinner and refreshments will be served after the presentations, and there will be plenty of time to network, and catch up with old and new acquaintances.
To complete the evening UNSW alumna, Associate Professor Michele Madigan, will give the keynote lecture of the night titled "Spotlight on the dark horses of the uvea - melanocytes, melanoma and much more"
We very much hope that you will be able to come along.
Professor Fiona Stapleton
Head of School, School of Optometry and Vision Science
To book please click here
CPD Points: 3
Registration: Please enter your details below. RSVP by 12 July 2017. Please include any dietary requirements.
Date & Time: 18 July 2017, 5:30pm – 9.00pm
Location: Rupert Myers Theatre, Rupert Myers Building (K15 map reference), UNSW, Kensington Campus (enter Gate 14, Barker Street)
Enquiries may be directed to (02) 9385 3295
- Eye movements in traumatic brain injury
- Do blue-blocking lenses affect visual performance?
- Innovative technology to extend depth of focus
- Refractive error profiles of school children in India
- Parapapillary atrophy in myopes and myopia control
Associate Professor Michele Madigan
Michele is an Associate Professor in the School of Optometry & Vision Science, and teaches in Ocular Anatomy and Physiology, encouraging a form-and-function approach to human eye anatomy. She is the Clinical Associate Professor (Honorary), Discipline of Ophthalmology, Save Sight Institute, Sydney Medical School, University of Sydney and is a Visiting Fellow at John Curtin School of Medical Research, Australian National University.
Michele's research is primarily directed at exploring and understanding the cell biology of human eye diseases in the context of normal human eye development and ageing. Currently her main areas of interest are: (a) understanding the microenvironment of primary eye tumours, especially melanoma, and (b) studying normal ageing in the human retina and choroid, and age-related macular degeneration (AMD), the most common cause of blindness for those over 50 years. Michele’s research is currently funded in these research areas with grants from NH&MRC, Sydney Foundation for Medical Research (re-named National Foundation for Medical Research and Innovation in 2014) and the Ophthalmic Research Institute of Australia (ORIA), with well-established national and international collaborations in these areas.
Spotlight on the dark horses of the uvea - melanocytes, melanoma and much more
Despite sharing similar origins, eye and skin melanocytes display distinct genetic and molecular characteristics. In the human eye, uveal melanocytes are now recognised to do much more than melanin-based light absorption, and may contribute to local immune responses and inflammation. We will explore features of these unique eye melanocytes, and highlight emerging ideas related to melanocyte transformation, and progression from naevus to primary eye melanoma. This will include advances in uveal melanoma diagnosis and prognostication and the challenges in treating these rare but potentially devastating eye tumours.
To book please click here